Chinese Journal of Pharmaceuticals
|
2026, 57(2): 236-242
• Pharmaceutical Management & Information •
Analysis and Insights on Microbial Control Issues in the FDA “Questions and Answers on Current Good Manufacturing Practice Regulations | Production and Process Controls”
Full
Hui LI1, Fufang TAO2, Sijin WANG3, Jinfang SHENG2, Shihong MA3, *
Affiliations
- 1.Shaanxi Shengdetailin Biological Safety Technical Testing Co., Ltd., Xi’an 710065
- 2.Shaanxi Center for Drug Evaluation, Xi’an 710065
- 3.National Institutes for Food and Drug Control, Beijing 100050
Published: 2026-02-10
doi: 10.16522/j.cnki.cjph.2026.02.015
Outline
李辉, 陶福芳, 王似锦, 绳金房, 马仕洪.
美国FDA《cGMP生产和过程控制相关法规问答》中微生物控制若干问题的分析与启示.
中国医药工业杂志,
2026
, 57
(2)
: 236
-242
.
DOI: 10.16522/j.cnki.cjph.2026.02.015
Hui LI, Fufang TAO, Sijin WANG, Jinfang SHENG, Shihong MA.
Analysis and Insights on Microbial Control Issues in the FDA “Questions and Answers on Current Good Manufacturing Practice Regulations | Production and Process Controls”[J].
Chinese Journal of Pharmaceuticals,
2026
, 57
(2)
: 236
-242
.
DOI: 10.16522/j.cnki.cjph.2026.02.015
Year 2026 volume 57 Issue 2
160
42
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.02.015
- Receive Date:2025-03-24
- Online Date:2026-11-05
- Published:2026-02-10